# Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study

> **NCT00501982** · PHASE4 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 208 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Newborn

## Interventions

- **DRUG:** Poractant alfa (Curosurf®)

## Key facts

- **NCT ID:** NCT00501982
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501982, "Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00501982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*